QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new ...

Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...

For the approximately one-in-twelve Canadians who have a rare disease, more bureaucracy is a matter of life and death ...

Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...

The actor James Van Der Beek, known for Dawson’s Creek, revealed at the end of 2024, when he was 47, that he’d been diagnosed ...

Final results from the VALOR trial and its open-label extension demonstrated the clinical benefit of tofersen in adults with ...

The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with ...

Codeveloped by the American Heart Association and the American Academy of Pediatrics, this publication presents the 2025 guidelines for basic life support during cardiopulmonary resuscitation and ...

State Medicaid programs are ending coverage of breakthrough weight-loss medications like Ozempic despite their proven effectiveness in treating obesity-related diseases. Weather warning issued before ...

Please provide your email address to receive an email when new articles are posted on . A new WHO guideline states adults with obesity could receive GLP-1 therapy as long-term treatment. The authors ...

MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL ...